Northern Trust
OKUR

Northern Trust’s OnKure Therapeutics OKUR Stock Holding History

Northern Trust’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.4K Hold
19,903
– – ﹤0.01% 4148
2025
Q4 		$57.7K Sell
19,903
-2,607
-12% -$7.8K ﹤0.01% 4257
2025
Q3 		$61.9K Hold
22,510
– – ﹤0.01% 4240
2025
Q2 		$53.8K Buy
22,510
+3,333
+17% +$8.74K ﹤0.01% 4218
2025
Q1 		$82.5K Hold
19,177
– – ﹤0.01% 4152
2024
Q4 		$165K Buy
19,177
+14,776
+336% +$224K ﹤0.01% 4040
2024
Q3 		$74.8K Sell
4,401
-7,385
-63% -$109K ﹤0.01% 4125
2024
Q2 		$178K Buy
11,786
+572
+5% +$9.7K ﹤0.01% 3898
2024
Q1 		$186K Sell
11,214
-450
-4% -$7.42K ﹤0.01% 3920
2023
Q4 		$187K Sell
11,664
-362
-3% -$22.6K ﹤0.01% 3918
2023
Q3 		$916K Buy
12,026
+2,018
+20% +$137K ﹤0.01% 3330
2023
Q2 		$657K Buy
10,008
+8,505
+566% +$685K ﹤0.01% 3471
2023
Q1 		$89.9K Buy
1,503
+312
+26% +$11.3K ﹤0.01% 4108
2022
Q4 		$27.7K Hold
1,191
– – ﹤0.01% 4415
2022
Q3 		$40K Hold
1,191
– – ﹤0.01% 4386
2022
Q2 		$31K Sell
1,191
-5,651
-83% -$132K ﹤0.01% 4548
2022
Q1 		$201K Buy
6,842
+487
+8% +$27.3K ﹤0.01% 4128
2021
Q4 		$544K Buy
6,355
+452
+8% +$33.2K ﹤0.01% 3776
2021
Q3 		$439K Sell
5,903
-942
-14% -$79.9K ﹤0.01% 3813
2021
Q2 		$639K Buy
+6,845
New +$763K ﹤0.01% 3636

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Northern Trust's OKUR Position: Q1 2026 in Review

Northern Trust held its OnKure Therapeutics (OKUR) position steady in Q1 2026 at 19,903 shares worth $82.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4148.

Northern Trust first reported a position in OKUR in Q2 2021 and has held it in 20 quarters since. The position peaked at $916K in Q3 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Northern Trust held 19,903 shares of OnKure Therapeutics worth $82.4K as of Q1 2026.
  • Northern Trust left its OnKure Therapeutics share count unchanged in Q1 2026.
  • OnKure Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4148 holding.
  • Northern Trust first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Northern Trust's OnKure Therapeutics position peaked at $916K in Q3 2023.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.